Single-cycle rituximab-induced immunologic changes in children: Enhanced in neuroimmunologic disease?
Angela Deyà-MartínezYadira GordónCristina Molina-AnguitaAlexandru VlageaMonica PiquerManel JuanAna Esteve-SoléJordi AntónÁlvaro MadridAna García-GarcíaAna M PlazaThaís ArmangueLaia AlsinaPublished in: Neurology(R) neuroimmunology & neuroinflammation (2020)
In our cohort, single-cycle RTX-induced dysgammaglobulinemia was enhanced in patients with neuroimmunologic diseases. Further studies are needed to confirm this observation.